A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.
about
ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programsNegative regulation of nuclear divisions in Caenorhabditis elegans by retinoblastoma and RNA interference-related genes.The HBP1 transcriptional repressor participates in RAS-induced premature senescenceHistone methyltransferase Suv39h1 represses MyoD-stimulated myogenic differentiationThe diverse functions of histone lysine methylationFunctional interdependence at the chromatin level between the MKK6/p38 and IGF1/PI3K/AKT pathways during muscle differentiation.Prediction of a key role of motifs binding E2F and NR2F in down-regulation of numerous genes during the development of the mouse hippocampus.NF-Y dependent epigenetic modifications discriminate between proliferating and postmitotic tissue.Specific loss of histone H3 lysine 9 trimethylation and HP1gamma/cohesin binding at D4Z4 repeats is associated with facioscapulohumeral dystrophy (FSHD).Chromatin: the interface between extrinsic cues and the epigenetic regulation of muscle regeneration.Transcription factor interactions and chromatin modifications associated with p53-mediated, developmental repression of the alpha-fetoprotein gene.Suv39h1 mediates AP-2α-dependent inhibition of C/EBPα expression during adipogenesis.Comparative analyses of SUV420H1 isoforms and SUV420H2 reveal differences in their cellular localization and effects on myogenic differentiation.A role for SUV39H1-mediated H3K9 trimethylation in the control of genome stability and senescence in WI38 human diploid lung fibroblastsMechanisms underlying the transcriptional regulation of skeletal myogenesis.Retinoblastoma protein and MyoD function together to effect the repression of Fra-1 and in turn cyclin D1 during terminal cell cycle arrest associated with myogenesis.The SWI/SNF subunit/tumor suppressor BAF47/INI1 is essential in cell cycle arrest upon skeletal muscle terminal differentiation.An epigenetic silencing pathway controlling T helper 2 cell lineage commitment.Independence of repressive histone marks and chromatin compaction during senescent heterochromatic layer formation.Epigenetic regulation of cardiac myocyte differentiation.Epigenetic regulation of myogenic gene expression by heterochromatin protein 1 alpha.Nucleoplasmic lamins and their interaction partners, LAP2alpha, Rb, and BAF, in transcriptional regulation.Direct control of cell cycle gene expression by proto-oncogene product ACTR, and its autoregulation underlies its transforming activity.The histone methyltransferase SUV39H1 suppresses embryonal rhabdomyosarcoma formation in zebrafish.Genome-wide remodeling of the epigenetic landscape during myogenic differentiation.Histone methyltransferase KMT1A restrains entry of alveolar rhabdomyosarcoma cells into a myogenic differentiated stateRb and p130 control cell cycle gene silencing to maintain the postmitotic phenotype in cardiac myocytesMammalian lysine histone demethylase KDM2A regulates E2F1-mediated gene transcription in breast cancer cellsFunctional Crosstalk Between Lysine Methyltransferases on Histone Substrates: The Case of G9A/GLP and Polycomb Repressive Complex 2Genome-Wide H3K4me3 Analysis in Angus Cattle with Divergent Tenderness.Lysine methyltransferase G9a methylates the transcription factor MyoD and regulates skeletal muscle differentiationConnections between epigenetic gene silencing and human disease.A fine balance: epigenetic control of cellular quiescence by the tumor suppressor PRDM2/RIZ at a bivalent domain in the cyclin a geneMulti-omic measurement of mutually exclusive loss-of-function enriches for candidate synthetic lethal gene pairs.The elements of human cyclin D1 promoter and regulation involved.Histone modifying and chromatin remodelling enzymes in cancer and dysplastic syndromes.The retinoblastoma tumor suppressor and stem cell biology.Epigenetic effects of the continuous exposure to peroxisome proliferator WY-14,643 in mouse liver are dependent upon peroxisome proliferator activated receptor alpha.Androgen receptor regulation by histone methyltransferase Suppressor of variegation 3-9 homolog 2 and Melanoma antigen-A11.Generation of a human embryonic stem cell line stably expressing high levels of the fluorescent protein mCherry
P2860
Q24296905-4A286B47-5FB1-4F3B-BC57-739820F78C1AQ24536288-E914AA03-09D2-4670-B900-21C50E4046D5Q24672298-EC950C49-4408-4042-833D-D9E6E45A1261Q28588561-D4FD9745-9892-45A4-9D5B-0710EAEF2ACEQ29614523-928C4854-422A-49AE-B69D-50F12EDFCC57Q30439474-A5BD06C9-3898-4419-886B-E89D39BA5B5CQ33252620-47F32C42-3948-4150-97BD-056A1AACA0E4Q33330321-A08DC15C-F7C9-4613-B559-E7142F733A2DQ33480945-7FCCC13C-F243-45E2-90CA-B996323D6232Q33593168-0544692B-C9DC-4E9C-BB5B-71A4B5CAD410Q33707631-01774C71-AF40-40E5-93A7-55394D4E23F9Q33743624-2FE453EE-1188-4F67-A3D3-6C3BEF8B6514Q33785780-EDA69EF3-B1EB-42D7-9B0C-B190DE22F83BQ34128604-5EB2AF11-8160-4488-ACC8-29A2457B4088Q34131477-0FB50221-850E-4A6C-AE64-B765AAFCF9C1Q34141108-0A83EB07-8F09-4007-8FB0-88FDE095934CQ34278363-429CB8A5-0A5E-4157-97C3-DFD2DBC7E5FFQ34286068-E617361C-39D8-4EAF-9FE8-58FBD04A96C8Q34337209-668E9C9D-B46E-4A66-AF1A-44F805EDB87DQ34449181-F56EB855-FBA7-4355-8D84-41A416DA28F9Q34625718-2351772D-7B8F-4C51-BFBB-891081CF40CEQ34654052-85B7997C-7EAB-4836-A44F-F6E929579E08Q34717365-497B2665-3736-410F-BEF2-CAEE5D08B75DQ34738256-740F50E7-4655-4ED0-B83B-7725FD76AC05Q35022027-57056C71-B91D-48BB-93F9-F82294CEE8B1Q35022234-97BB7970-79BB-4EB0-A07A-8D84A22D368AQ35156976-CFA037AD-1671-44A4-96C3-7AB09754FDD3Q35207590-B88DED18-3B37-40AE-AD5F-C64696A31A24Q35609473-03CD4F25-324A-40D8-8A3D-73ED2226D997Q35667281-5F882054-A769-45BC-9891-59E9F74C0FEEQ35735009-9F3938AB-E770-42FD-A169-451A35DF8E7CQ35843804-C88FD4C8-F065-4528-82A5-B5E48D9B24E2Q35885911-DBE9AEA5-DE46-4391-A928-D1CDB32147A0Q35897125-CCA599A0-0A17-4F44-A41D-1DB66E86754EQ36002446-F2A4E66D-4398-4E74-AB9D-F9CCB189D065Q36088957-F3F375C7-8730-4843-BE6C-1C51CDAD5E40Q36110891-4AA7D2A7-F0C6-41F5-AC85-1D6FCC568D93Q36202782-5C89DF42-B9CD-4BED-A2AE-98EB6FF04533Q36237251-D61B779C-4EA4-4D9A-995D-5BBDB25B17B5Q36237939-6DA46514-98C0-4899-BE21-2EEA1A55D215
P2860
A Suv39h-dependent mechanism for silencing S-phase genes in differentiating but not in cycling cells.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
A Suv39h-dependent mechanism f ...... ating but not in cycling cells
@nl
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@ast
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en-gb
type
label
A Suv39h-dependent mechanism f ...... ating but not in cycling cells
@nl
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@ast
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en-gb
prefLabel
A Suv39h-dependent mechanism f ...... ating but not in cycling cells
@nl
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@ast
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en-gb
P2093
P2860
P3181
P356
P1433
P1476
A Suv39h-dependent mechanism f ...... ting but not in cycling cells.
@en
P2093
Anna Polesskaya
Florence Cabon
Hakima Yahi
Irina Naguibneva
Lauriane Fritsch
Philippe Robin
Redha Sekhri
Valentina Guasconi
P2860
P304
P3181
P356
10.1038/SJ.EMBOJ.7600074
P407
P577
2004-02-05T00:00:00Z